Cytokinetics | CYTK - Current Liabilities

Stock Price
65.32
Daily Change
-0.16 -0.24%
Monthly
4.70%
Yearly
61.56%
Q2 Forecast
63.92

Cytokinetics reported $202.45M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Acadia Pharmaceuticals USD 277.11M 79.47M Dec/2025
Amgen USD 25.49B 3.7B Dec/2025
Arca Biopharma USD 15.37M 5.59M Dec/2025
Bayer EUR 32.58B 3.63B Dec/2025
Biogen USD 3.35B 59.4M Dec/2025
Brainstorm Cell Therapeutics USD 11.01M 1.98M Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Capricor Therapeutics USD 35.84M 7.69M Dec/2025
Cytokinetics USD 202.45M 60.31M Dec/2025
Eisai JPY 387.67B 9.42B Dec/2025
Eli Lilly USD 35.23B 4.91B Dec/2025
Exelixis USD 405.64M 31.86M Dec/2025
Geron USD 113.82M 26.11M Dec/2025
Halozyme Therapeutics USD 177.09M 660.14M Dec/2025
Ionis Pharmaceuticals USD 783M 120.46M Dec/2025
Ligand Pharmaceuticals USD 37.45M 6.91M Dec/2025
Merck USD 28.63B 2.59B Sep/2025
Novartis USD 27.28B 4.72B Dec/2025
Pfizer USD 36.6B 1.13B Sep/2025
Regeneron Pharmaceuticals USD 4.37B 56.7M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 30.01B 1.66B Mar/2026